Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Curcumin decreases specificity protein expression in bladder cancer cells.

Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R 3rd, Li X, Safe S.

Cancer Res. 2008 Jul 1;68(13):5345-54. doi: 10.1158/0008-5472.CAN-07-6805.

2.

Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.

Jutooru I, Chadalapaka G, Sreevalsan S, Lei P, Barhoumi R, Burghardt R, Safe S.

Exp Cell Res. 2010 Aug 1;316(13):2174-88. doi: 10.1016/j.yexcr.2010.04.027. Epub 2010 May 8.

3.

Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.

Jutooru I, Chadalapaka G, Lei P, Safe S.

J Biol Chem. 2010 Aug 13;285(33):25332-44. doi: 10.1074/jbc.M109.095240. Epub 2010 Jun 9.

4.
5.

Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.

Chadalapaka G, Jutooru I, Burghardt R, Safe S.

Mol Cancer Res. 2010 May;8(5):739-50. doi: 10.1158/1541-7786.MCR-09-0493. Epub 2010 Apr 20.

6.

Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.

Gandhy SU, Kim K, Larsen L, Rosengren RJ, Safe S.

BMC Cancer. 2012 Nov 30;12:564. doi: 10.1186/1471-2407-12-564.

7.

Celastrol decreases specificity proteins (Sp) and fibroblast growth factor receptor-3 (FGFR3) in bladder cancer cells.

Chadalapaka G, Jutooru I, Safe S.

Carcinogenesis. 2012 Apr;33(4):886-94. doi: 10.1093/carcin/bgs102. Epub 2012 Feb 14.

8.

Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors.

Pathi S, Jutooru I, Chadalapaka G, Nair V, Lee SO, Safe S.

PLoS One. 2012;7(10):e48208. doi: 10.1371/journal.pone.0048208. Epub 2012 Oct 26.

9.

Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.

Chintharlapalli S, Papineni S, Abdelrahim M, Abudayyeh A, Jutooru I, Chadalapaka G, Wu F, Mertens-Talcott S, Vanderlaag K, Cho SD, Smith R 3rd, Safe S.

Int J Cancer. 2009 Oct 15;125(8):1965-74. doi: 10.1002/ijc.24530.

10.

Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.

Mertens-Talcott SU, Noratto GD, Li X, Angel-Morales G, Bertoldi MC, Safe S.

Mol Carcinog. 2013 Aug;52(8):591-602. doi: 10.1002/mc.21893. Epub 2012 Mar 7.

11.

Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.

Papineni S, Chintharlapalli S, Abdelrahim M, Lee SO, Burghardt R, Abudayyeh A, Baker C, Herrera L, Safe S.

Carcinogenesis. 2009 Jul;30(7):1193-201. doi: 10.1093/carcin/bgp092. Epub 2009 Apr 30.

12.

Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors.

Nair V, Pathi S, Jutooru I, Sreevalsan S, Basha R, Abdelrahim M, Samudio I, Safe S.

Carcinogenesis. 2013 Dec;34(12):2870-9. doi: 10.1093/carcin/bgt231. Epub 2013 Jun 26.

13.

Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.

Chintharlapalli S, Papineni S, Ramaiah SK, Safe S.

Cancer Res. 2007 Mar 15;67(6):2816-23.

14.

Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.

Pathi S, Li X, Safe S.

Mol Carcinog. 2014 Feb;53 Suppl 1:E53-61. doi: 10.1002/mc.22010. Epub 2013 May 14.

PMID:
23670891
15.

Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Chadalapaka G, Jutooru I, Sreevalsan S, Pathi S, Kim K, Chen C, Crose L, Linardic C, Safe S.

Int J Cancer. 2013 Feb 15;132(4):795-806. doi: 10.1002/ijc.27730. Epub 2012 Aug 3. Erratum in: Int J Cancer. 2015 Sep 15;137(6):E9.

16.

GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27a: ZBTB10-specificity protein pathway.

Pathi SS, Jutooru I, Chadalapaka G, Sreevalsan S, Anand S, Thatcher GR, Safe S.

Mol Cancer Res. 2011 Feb;9(2):195-202. doi: 10.1158/1541-7786.MCR-10-0363. Epub 2010 Dec 14.

17.

Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.

Jutooru I, Chadalapaka G, Abdelrahim M, Basha MR, Samudio I, Konopleva M, Andreeff M, Safe S.

Mol Pharmacol. 2010 Aug;78(2):226-36. doi: 10.1124/mol.110.064451. Epub 2010 May 20. Erratum in: Mol Pharmacol. 2011 Feb;79(2):336.

18.

Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.

Abdelrahim M, Baker CH, Abbruzzese JL, Safe S.

J Natl Cancer Inst. 2006 Jun 21;98(12):855-68.

PMID:
16788159
19.

The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis.

Noratto GD, Jutooru I, Safe S, Angel-Morales G, Mertens-Talcott SU.

Mol Nutr Food Res. 2013 Sep;57(9):1638-48. doi: 10.1002/mnfr.201200609. Epub 2013 Mar 8.

PMID:
23471840
20.

Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.

Gao Y, Shi Q, Xu S, Du C, Liang L, Wu K, Wang K, Wang X, Chang LS, He D, Guo P.

Int J Mol Sci. 2014 Aug 28;15(9):15173-87. doi: 10.3390/ijms150915173.

Supplemental Content

Support Center